Adverse Effects & Toxicology PNLE Questions
Introduction
The live Tangerine inventory contains 7 original PNLE-style practice questions for Adverse Effects & Toxicology. The inventory was last updated August 12, 2026, so use this count to plan practice rather than to predict an exam form.
Study this topic as a safety-decision set: recognize an adverse reaction, separate an expected effect from toxicity, identify a likely overdose or toxic syndrome, connect a harmful effect to the appropriate antidote or urgent treatment, and select monitoring that shows deterioration or response. The scope includes reaction recognition, toxicity, overdose, antidotes, and toxicity monitoring. A contraindicated order without an actual harmful effect belongs to Medication Safety & Administration.
Under the 2025 Enhanced TOS, this is not a separate official test subject. It is a Tangerine pedagogical lens mapped across relevant competencies in the official five-subject PNLE TOS; exact microtopic distribution varies by exam form. Use these questions to rehearse clinical judgment across those competencies.
Key concepts
- Recognize the toxic pattern first
Recognize: Link the medication or substance exposure to a new cluster of findings, its timing, and the affected system; assess airway, breathing, circulation, and mental status when the patient is unstable.
Decide: Identify the most urgent harmful effect and escalate care while gathering the exposure history.
Avoid: Anchoring on one symptom or waiting for a named diagnosis before responding to deterioration. - Separate an expected effect from toxicity
Recognize: With magnesium sulfate therapy, the intended reduction in neuromuscular excitability differs from markedly depressed reflexes, respiratory depression, hypotension, or reduced urine output.
Decide: Compare the finding with the treatment goal, assess the patient’s trend, and report or escalate signs of excessive effect according to protocol.
Avoid: Labeling every medication effect as an overdose or dismissing a worsening cluster because one finding may be expected. - Target the cause of a toxic syndrome
Recognize: Suspected neuroleptic malignant syndrome may present with severe rigidity, altered mental status, fever, and autonomic instability after exposure to a dopamine-blocking medication.
Decide: Withhold further exposure according to protocol, notify the appropriate clinician urgently, and support close assessment of airway, temperature, circulation, and complications.
Avoid: Treating fever alone while overlooking the medication cause and the broader pattern. - Match the antidote to the harmful agent and effect
Recognize: Naloxone is indicated when an opioid effect is producing clinically significant respiratory depression; the key assessment is inadequate ventilation, not simply drowsiness.
Decide: Administer as ordered to improve ventilation, then continue reassessment for response, recurrence, and withdrawal-related problems.
Avoid: Assuming that every unresponsive patient has opioid toxicity or stopping assessment once the patient becomes more alert. - Monitor aminoglycoside toxicity by organ system
Recognize: Aminoglycosides can produce renal injury and ototoxic effects; new tinnitus, hearing change, balance problems, altered urine output, or worsening renal results require attention.
Decide: Trend renal function and urine output, ask about hearing and balance, and review ordered drug-level monitoring and therapy with the care team.
Avoid: Waiting for profound hearing loss or severe renal deterioration before reporting a change. - Prioritize instability in severe stimulant toxicity
Recognize: Severe cocaine toxicity can involve agitation, hyperthermia, seizures, chest symptoms, or dysrhythmias, making the patient’s physiologic status the immediate concern.
Decide: Prioritize airway and circulation, reduce stimulation, obtain urgent assistance, and support treatment directed at the active complication.
Avoid: Choosing a single medication before identifying the unstable body system and the treatment target.
What to expect on the PNLE
The 7-item inventory supports several PNLE-style question forms: recognizing a toxic syndrome, identifying the priority treatment target, distinguishing an expected medication effect from toxicity, selecting toxicity monitoring, and identifying when an antidote is indicated. Representative scope evidence includes neuroleptic malignant syndrome, severe cocaine toxicity, substance-use toxicology, aminoglycoside renal and auditory effects, magnesium sulfate effects, and naloxone indication.
The live difficulty distribution is easy=1, medium=4, and hard=2. Its Bloom distribution is applying=4, remembering=1, analyzing=1, and evaluating=1, so practice should emphasize using clinical cues in a patient situation while still retrieving key indications and adverse-effect patterns.
- Applying: Connect the exposure and findings to the safest immediate nursing action or monitoring plan.
- Analyzing: Separate overlapping findings and identify the syndrome or organ system driving the priority.
- Evaluating: Judge which intervention or response best protects the patient as the condition changes.
- Remembering: Retrieve a cause-specific indication, such as the clinical situation in which naloxone is appropriate.
Exact topic distribution varies by exam form. The inventory supports these reasoning tasks but does not establish a guaranteed count for any named drug, toxin, or syndrome.
Study tips
- Begin with diagnostic practice. Complete all 7 inventory questions without opening the rationale first. Beside each answer, record your confidence and the decision you were trying to make: recognition, priority action, antidote, expected effect, or monitoring.
- Use focused retrieval for the weak decision. Make a comparison table by hand rather than copying a drug list. A useful layout is:Drug or substance | Expected effect | Toxicity cue | Immediate nursing decision | Follow-up monitoring
Magnesium sulfate | intended neuromuscular effect | excessive depression | reassess and escalate | reflexes, breathing, blood pressure, urine output
Amikacin | antimicrobial effect | hearing, balance, or renal change | report and review therapy | renal status and auditory findings - Review rationales and errors. For every wrong or guessed answer, identify the stem cue you missed, the safer action, and why each competing option was less appropriate. Separate a knowledge gap from a prioritization error.
- Retry with spacing. After a gap, answer the same items from memory before rereading explanations. Then write one brief rule for each error, such as matching the antidote to the toxic agent and monitoring the response after treatment.
- Finish with mixed timed practice. Combine adverse effects and toxicology with Medication Safety & Administration, Pharmacology Principles, and Special Populations Pharmacology. Review whether you recognized the harmful effect, selected the priority action, and chose monitoring that detects worsening or recurrence.
Common mistakes to avoid
- Confusing an expected effect with toxicity. A learner may treat any reduced reflex response during magnesium sulfate therapy as proof of overdose. The corrective cue is the whole safety pattern: markedly depressed reflexes together with respiratory, blood pressure, urine-output, or general-status changes requires escalation.
- Selecting naloxone from altered consciousness alone. The indication is an opioid effect with clinically significant respiratory depression. Assess ventilation and continue monitoring after treatment because toxic effects can recur.
- Classifying a contraindicated order as an adverse reaction. An unsafe order without a resulting harmful effect belongs to Medication Safety & Administration. This topic requires evidence of an adverse reaction, toxicity, overdose, or a monitoring problem.
- Waiting for laboratory confirmation during obvious instability. Severe toxicity may first be identified through airway, breathing, circulation, mental-status, temperature, seizure, or rhythm findings. Stabilization and urgent escalation should proceed while confirmation and targeted treatment are arranged.
- Monitoring only one aminoglycoside toxicity pathway. Focusing on renal findings can hide cochlear or vestibular injury, while focusing only on hearing can miss renal deterioration. Review both organ systems and report new tinnitus, hearing or balance changes, urine-output changes, and concerning renal trends.
- Stopping assessment after the antidote or first intervention. An antidote targets a harmful effect; it does not replace reassessment. Recheck the response, ongoing airway and breathing status, and signs that the original toxicity or a treatment complication persists.
Try a question
A real Adverse Effects & Toxicology question from our bank. Give it a shot.
A patient treated with haloperidol develops a temperature of 40 °C, generalized rigidity, confusion, diaphoresis, and labile blood pressure. The team suspects neuroleptic malignant syndrome. Which action belongs to the medication-management portion of the emergency response?
Neuroleptic malignant syndrome (NMS) is a rare but life-threatening reaction to antipsychotic medications, primarily characterized by fever, severe muscular rigidity, altered mental status, autonomic dysfunction (such as labile blood pressure), and diaphoresis. NMS is most frequently associated with dopamine antagonists like haloperidol and requires prompt recognition and intervention to prevent morbidity and mortality. The emergency response to NMS involves rapid discontinuation of the causative agent, supportive care, and monitoring for complications such as rhabdomyolysis and renal failure.
Why the correct option is correct
B. Placing the scheduled antipsychotic agent (haloperidol) on hold immediately and urgently communicating the last dose and symptom onset addresses the cornerstone of medication management in neuroleptic malignant syndrome. Immediate discontinuation of the offending agent halts further dopamine antagonism, which is the pathophysiologic driver of NMS. Accurate and urgent communication of the last dose and timeline of symptom progression is necessary for the medical team to determine cause, anticipate severity, and prioritize further interventions such as pharmacologic muscle-relaxant therapy, ICU monitoring, or transfer. Early cessation is the single most effective medication-related intervention and must occur at the first suspicion of NMS.
Clinical pearl: In NMS, always prioritize immediate discontinuation of all dopamine-blocking agents. Continuing antipsychotics may worsen symptom severity and delay stabilization.
Why the other options are incorrect
| Option | Why it is wrong |
|---|---|
| A | Isotonic IV fluids are essential for supportive management and renal protection but do not constitute medication management. They do not address the causative drug action, which is the urgent priority in NMS. |
| C | Active cooling and core monitoring focus on temperature control, not on medication management. These are supportive steps, not the targeted pharmacologic intervention against the disease mechanism. |
| D | Laboratory studies for muscle breakdown and renal status are important for monitoring complications but are diagnostic and evaluative actions, not direct medication management. |
- Videbeck, S. L. (2011). Psychiatric-Mental Health Nursing (5th ed.). Lippincott Williams & Wilkins.
More Adverse Effects & Toxicology questions
7 questions available. Sign up to practice all of them.
A patient with acute cocaine toxicity is severely agitated, hyperthermic, and at risk for seizures. After supporting the airway and breathing, which plan should the nurse implement first?
After cocaine use, a client has agitation, chest pain, tachycardia, hypertension, and hyperthermia. Which interpretation best guides priority care?
A client is prescribed amikacin for a severe infection. Which instruction should the nurse emphasize to the client regarding potential side effects?
References and further reading
- PRC Enhanced Table of Specifications for the Nurses Licensure Examination official
The current public competency and cognitive-level blueprint, effective from the November 2025 NLE onward. - Tangerine Prep PNLE Reviewer question bank
The live source for the published question count, question previews, rationales, and inventory distributions on this page.
How this page is built
The counts and distributions on this page come from Tangerine Prep's live published question bank. The source inventory was last updated on August 12, 2026.
The questions are original PNLE-style practice items, not recalled or leaked board questions. Topic scope follows Tangerine's pedagogical taxonomy and is mapped to the PRC 2025 Enhanced Table of Specifications, effective from the November 2025 NLE onward. Exact topic distribution varies by exam form.